Prevention of chloroquine-induced electroretinographic damage by a new platelet-activating factor antagonist, BN 50730.


Chloroquine retinopathy is a severe toxic retinal impairment which may result in loss of vision by alterations of the retinal pigment epithelium and photoreceptors. Currently, there is no specific treatment for this retinopathy. Platelet-activating factor (PAF) is known to modulate retinal function and is one of the major immunomediators of the retina. In… (More)


  • Presentations referencing similar topics